Trial
NCT01187446
Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Stanford University
Collaborators
—
Condition
Cutaneous Lymphoma
Intervention
Total skin electron beam therapy (TSEBT)
Why stopped
Business decision by funding source
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-11-20